ADVA-BIOTIO KIDS MAX CAPSULES (Each capsule contains Zinc 10mg/ Oligofructose 600mg/ Probiotic blend 400mg )

Dosage

Children: Paediatric dosing for blends is not commonly standardized and should be approached with caution. Consultation with a healthcare provider is recommended to determine appropriate dosing based on the specific blend and the child's health needs.

Adults: Dosage for adult blends varies widely depending on the specific formulation and purpose. It is important to refer to the specific product label or consult a healthcare professional for guidance.

Mechanism of action

The mechanism of action for a blend depends on its individual components. For example, if the blend contains herbal extracts, each herb may have its own active compounds that interact with various biochemical pathways in the body, such as antioxidant activity, anti-inflammatory effects, or modulation of neurotransmitter levels. These mechanisms can vary significantly based on the specific herbs or substances included in the blend.

Pharmacodynamics

Pharmacodynamics of a blend involves understanding how the individual components affect the body. This can include synergistic effects where the combined action of substances leads to enhanced therapeutic effects, or antagonistic effects where one substance may reduce the efficacy of another. The overall pharmacodynamic profile will depend on the blend's composition and the dose of each ingredient.

Pharmacokinetics

Pharmacokinetics of a blend varies based on the components used. Factors such as absorption, distribution, metabolism, and excretion can change according to the specific substances involved. For instance, some herbal constituents may be rapidly absorbed, while others might have delayed onset of action due to slow metabolism or elimination processes. The presence of multiple ingredients may also influence the pharmacokinetics of each other through various interactions.

Pregnancy

Consult a healthcare provider before use. The effects on fetal development are not well-studied, and potential risks should be assessed based on the specific formulation and individual health circumstances.

Breast-feeding

Consult a healthcare provider before use. Safety during breastfeeding is not well-established, and potential risks to the infant should be considered.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Dietary supplement for gut health
• Prebiotic agent to support healthy gut flora
• Management of constipation
• Support for digestive health

Dosage

Children: Refer to the BNF for Children for appropriate dosing recommendations, as it is dependent on age and specific indications.

Adults: Refer to the relevant guidelines for specific dosing recommendations, as it can vary based on formulation and purpose.

Mechanism of action

Oligofructose acts as a prebiotic, selectively stimulating the growth and/or activity of beneficial gut bacteria, such as Bifidobacteria and Lactobacilli. This fermentation process leads to the production of short-chain fatty acids, which can provide various health benefits, including improved gut health and enhanced mineral absorption.

Pharmacodynamics

Due to its prebiotic properties, oligofructose contributes to improved gut microbiota composition and activity. It enhances the intestinal barrier function and may also contribute to immune modulation. The fermentation of oligofructose by gut bacteria generates short-chain fatty acids, which play a role in energy metabolism and may have anti-inflammatory effects.

Pharmacokinetics

Oligofructose is not significantly absorbed in the upper gastrointestinal tract. Instead, it reaches the colon, where it is fermented by gut microbiota. The rate of fermentation and the resulting production of short-chain fatty acids can vary based on the individual's gut flora and the amount of oligofructose ingested. Its effects are generally dose-dependent.

Pregnancy

Oligofructose is generally considered safe for use during pregnancy. However, it is advisable to consult a healthcare professional before use.

Breast-feeding

Oligofructose is considered safe during breastfeeding, but consulting a healthcare professional is recommended before use.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• {'type': 'Powder', 'description': 'Oligofructose is commonly available in powder form for easy incorporation into food and beverages.'}
• {'type': 'Granules', 'description': 'Granulated formulations are also available, suitable for mixing with various food products.'}

Indications

• Antibiotic-associated diarrhea
• Irritable bowel syndrome
• Inflammatory bowel disease
• Gastroenteritis
• Lactose intolerance
• Immune system support
• Prevention of infections in certain populations

Dosage

Children: Refer to specific product guidelines, as dosing may vary based on the probiotic strain, age, and clinical indication.

Adults: Refer to specific product guidelines, as dosing may vary based on the probiotic strain and clinical indication.

Mechanism of action

Probiotics exert their effects through several mechanisms, including the competition with pathogenic microorganisms for adhesion sites in the gut, production of antimicrobial substances such as bacteriocins, modulation of the immune system, and enhancement of the intestinal barrier function. They may also influence gut microbiota composition and metabolic activity, contributing to improved gut health.

Pharmacodynamics

The pharmacodynamics of probiotics involve their ability to adhere to the intestinal epithelium, survive gastric acid and bile, and proliferate in the gut. These properties enable them to exert beneficial effects on gut health, including the suppression of pathogenic bacteria, enhancement of mucosal immunity, and modulation of gut inflammatory responses. Additionally, they may produce short-chain fatty acids and other metabolites that promote gut health.

Pharmacokinetics

Probiotics generally exhibit a transient presence in the gastrointestinal tract, with limited absorption into the systemic circulation. The survival of probiotic strains is influenced by factors such as the formulation, the presence of prebiotics, and the individual's gastrointestinal environment. They typically reach peak concentrations in the gut shortly after administration, and their effects are often dose-dependent.

Adverse effects

• Gastrointestinal discomfort
• Bloating
• Gas
• Diarrhea

Precautions

• Caution in patients with a history of gastrointestinal disorders
• Consider potential immunocompromised state in patients

Pregnancy

Generally considered safe, but consult healthcare provider.

Breast-feeding

Generally considered safe, but consult healthcare provider.

Storage

Store in a cool, dry place. Avoid exposure to moisture.

Formulations

• Capsules
• Powders for oral suspension
• Tablets